Close Menu

copy number analysis

The move will add Chronix's proprietary technology for blood-based immune therapy monitoring and transplant rejection testing to Oncocyte's existing test menu.

Several groups are comparing Bionano with standard cytogenetic assays like karyotyping, FISH, or array CGH for blood cancer or genetic disease testing.

The findings, published last week, have prompted Belgian medical genetics centers to routinely report maternal incidental findings from NIPT.